Karo Pharma AB
Develops, markets, and sells a broad portfolio of everyday healthcare products.
KARO | ST
Overview
Corporate Details
- ISIN(s):
- NO0010308240 (+4 more)
- LEI:
- 213800G54Z51LOPGTA79
- Country:
- Sweden
- Address:
- BOX 16184, 103 24 STOCKHOLM
- Website:
- https://www.karohealthcare.com/
- Sector:
- Manufacturing
Description
Karo Pharma AB, operating as Karo Healthcare, is a healthcare company that develops, markets, and sells a broad portfolio of everyday healthcare products. The company's offerings are designed to prevent illness and treat common health problems, empowering consumers to manage their daily well-being. The portfolio consists of various branded medicines and consumer healthcare products distributed through pharmacies and directly to healthcare providers. With products available in over 90 countries, the company focuses on becoming a leading force in its sector by employing a consumer-centric approach, strategic innovation, and omnichannel excellence.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-05-31 16:00 |
Kommuniké från Karo Pharmas årsstämma 2022
|
Swedish | 1.4 MB | ||
| 2022-05-27 16:00 |
Ändringar i Karo Intressenter AB:s förslag avseende val av styrelse till Karo P…
|
Swedish | 1.1 MB | ||
| 2022-05-02 18:30 |
KALLELSE TILL ÅRSSTÄMMA I KARO PHARMA AKTIEBOLAG
|
Swedish | 4.9 MB | ||
| 2022-04-19 08:30 |
Karo Pharmas företrädesemission fulltecknad
|
Swedish | 3.6 MB | ||
| 2022-04-19 08:30 |
Karo Pharma’s rights issue fully subscribed
|
English | 3.6 MB | ||
| 2022-04-01 13:30 |
Karo Pharma slutför förvärvet av E45® från Reckitt
|
Swedish | 21.3 KB | ||
| 2022-04-01 13:30 |
Karo Pharma completes the acquisition of the E45® brand from Reckitt
|
English | 46.1 KB | ||
| 2022-03-23 12:00 |
Karo Pharma offentliggör prospekt avseende företrädesemissionen och erhåller go…
|
Swedish | 460.3 KB | ||
| 2022-03-23 12:00 |
Karo Pharma publishes prospectus relating to the rights issue and receives appr…
|
English | 438.3 KB | ||
| 2022-03-16 08:00 |
Karo Pharma resolves on a fully guaranteed rights issue of approximately SEK 2.…
|
English | 156.1 KB | ||
| 2022-03-16 08:00 |
Karo Pharma beslutar om en fullt garanterad företrädesemission om cirka 2,5 mil…
|
Swedish | 156.3 KB | ||
| 2022-03-10 14:00 |
Karo Pharma receives approval to delist the Company’s share from Nasdaq Stockho…
|
English | 697.2 KB | ||
| 2022-03-10 14:00 |
Karo Pharma erhåller villkorat godkännande om avnotering av Bolagets aktier frå…
|
Swedish | 696.0 KB | ||
| 2022-03-09 12:00 |
Karo Pharma applies for delisting of the Company’s shares from Nasdaq Stockholm…
|
English | 51.0 KB | ||
| 2022-03-09 12:00 |
Karo Pharma ansöker om avnotering av Bolagets aktier från Nasdaq Stockholm i sa…
|
Swedish | 51.7 KB |
Automate Your Workflow. Get a real-time feed of all Karo Pharma AB filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Karo Pharma AB
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Karo Pharma AB via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
